First-line Chemotherapy for Recurrent Cervical Cancer

Clinical trial NCT04188847 · COMPLETED

Trial details

NCT number: NCT04188847
Sponsor: Lei Li
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Cervical Carcinoma Persistent Advanced Cervical Carcinoma Chemotherapy Vascular Endothelial Growth Factor 2 Inhibitor Apatinib Targeted Therapy

Start date: 2019-12-06
Primary completion: 2022-02-06
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.